PI
HCAT icon

PEAK6 Investments’s Health Catalyst HCAT Stock Holding History

PEAK6 Investments’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-300
Closed -$3K – 4745
2022
Q3 		$3K Sell
300
-100
-25% -$1.32K ﹤0.01% 4701
2022
Q2 		$6K Buy
+400
New +$6.82K ﹤0.01% 5881
2021
Q4 		– Sell
-5,000
Closed -$250K – 5381
2021
Q3 		$250K Sell
5,000
-2,800
-36% -$153K ﹤0.01% 3828
2021
Q2 		$433K Buy
7,800
+7,700
+7,700% +$410K ﹤0.01% 3357
2021
Q1 		$5K Buy
+100
New +$4.84K ﹤0.01% 4713
2020
Q3 		– Sell
-8,000
Closed -$233K – 4577
2020
Q2 		$233K Buy
+8,000
New +$221K ﹤0.01% 3284

Other funds holding HCAT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
DG
Daventry Group New York $87.8M AUM 3.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PEAK6 Investments's HCAT Position: Q4 2022 in Review

PEAK6 Investments sold out of Health Catalyst (HCAT) in Q4 2022, closing a stake of 15,856 shares — an estimated $154K sold.

PEAK6 Investments first reported a position in HCAT in Q1 2021 and held it in 4 quarters. The position peaked at $285K in Q2 2022. 167 funds tracked by Wall St. Rank hold HCAT as of Q4 2022.

  • PEAK6 Investments reported no remaining Health Catalyst position as of Q4 2022 after selling out during the quarter.
  • PEAK6 Investments sold 15,856 Health Catalyst shares in Q4 2022, an estimated $154K.
  • PEAK6 Investments first reported a position in Health Catalyst in Q1 2021 and held it in 4 quarters.
  • PEAK6 Investments's Health Catalyst position peaked at $285K in Q2 2022.
  • 167 funds tracked by Wall St. Rank held Health Catalyst as of Q4 2022.

Based on PEAK6 Investments's 13F filing for Q4 2022, filed 10 Feb 2023.